BioComm Network, Inc retweeted
@AeriePharma receives U.S. FDA approval for its second first-of-a-kind #glaucoma therapy. Proud of our team! bit.ly/2Ci4Jam
Our VISIONaerie co-founder describes the search for a new way to treat glaucoma and the path ahead in #ophthalmology lnkd.in/eMB7SvC
BioComm Network, Inc retweeted
Give Sight, Give Delight: Aerie Pharmaceuticals will match attendee donations to @ASCRStweets's charitable programs up to $25,000. Click to donate! buff.ly/2ERaoTm #ASCRSASOA2018 #GiveSight buff.ly/2ERaoTm
BioComm Network, Inc retweeted
Aerie Pharmaceuticals to match @ASCRSFoundation donations during annual @ASCRStweets meeting goo.gl/65z64Z #ASCRS2018 #ASCRSASOA2018
CLICK HERE TO DONATE: ascrsfoundation.org/give
Congratulations to the entire Aerie Pharmaceuticals team, clinical investigators, and patients on early approval of Rhopressa #glaucoma
lnkd.in/gJyC465
BioComm Network, Inc retweeted
FDA approves Aerie Pharmaceuticals' netarsudil ophthalmic solution 0.02% (Rhopressa) for the lowering of elevated IOP in patients with open-angle glaucoma or ocular hypertension bit.ly/2kHYOSo
The American Cancer Society celebrates this expansion of resources for people fighting #cancer in Orange County! lnkd.in/gjttzjq
Congratulations to the Aerie Pharmaceuticals team on strong DODAC support for Rhopressa #glaucoma lnkd.in/gfWYVJz
BioComm Network, Inc retweeted
Balanced/thoughtful view from Guido Lanza, CEO of Numerate, on AI in drug discovery. No claims of 6 yrs to 6 days! wxpress.wuxiapptec.com/insid…
Ropressa DODAC is October 13. #glaucoma nitter.gq/OphthTimes/status/9106…
Aerie Announces FDA Advisory Committee Meeting for Rhopressa (netarsudil ophthalmic solution) 0.02% buff.ly/2xnOMxl #ophthalmology
Aerie Pharmaceuticals initiates Phase 3 comparison of fixed dose combos to support Roclatan EU submission #glaucoma…lnkd.in/gPUM88F
Huge thanks to AGRI-TURF DISTRIBUTING LLC , Tustin Ranch Golf Club, sponsors and golfers for driving the greens for…lnkd.in/gMPA9zF
Congrats to friend and mentor, Grant Freeman, for well-deserved recognition as a 2017 St. George National Award winn…lnkd.in/gh9mZbp
Aerie Pharmaceuticals reports strong 12-month data from Mercury 1 trial of Roclatan #glaucoma #ophthalmology lnkd.in/gjUzfcC
1
BioComm Network, Inc retweeted
Trending Topics in the latest ARVONews: New #glaucoma therapies in the works. ow.ly/sCOj30cWMGi
The latest leader to arise from OC's wellspring of #innovation in #ophthalmology? Aerie Pharmaceuticals at @OCTANeOC lnkd.in/g9nMVh3









